Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2027

Conditions
SalidrosideRandomized Controlled TrialIn Vitro FertilizationAssisted Reproductive Technology
Interventions
DRUG

Salidroside

In the salidroside group, oral administration of rhodiola capsules (Xizang Gaoyuan 'an Biotechnology Development Co., LTD.) was started on the day of entering the COS cycle, once a day, 2 pills at a time, and the drug was stopped on the trigger day.

Trial Locations (1)

Unknown

The Second Hospital of Shandong University,, Jinan

All Listed Sponsors
lead

The Second Hospital of Shandong University

OTHER